Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Lunning

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|October 18, 2019
CAR T-Cell Therapy in Hematologic Malignancies: A Voyage in ProgressSarah A Holstein, Matthew A Lunning
Blood Reviews|October 16, 2012
Management of indolent lymphoma: where are we now and where are we goingMatthew A Lunning, Julie M Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curveMatthew A Lunning, Alison J Moskowitz, Steven Horwitz
Blood|March 12, 2014
How I treat the peripheral T-cell lymphomasAlison J Moskowitz, Matthew A Lunning, Steven M Horwitz
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for longAlison J Moskowitz, Matthew A Lunning, Steven M Horwitz
Journal of Oncology Practice|August 16, 2017
Detection and Treatment of Monoclonal Gammopathy of Renal Significance With Progression to Light Chain Deposition DiseaseGheorghe Ciprian Cazan, Kirk Foster, Matthew A Lunning, et al.
Lancet (London, England)|February 4, 2017
Non-Hodgkin lymphomaJames O Armitage, Randy D Gascoyne, Matthew A Lunning, et al.
Blood Advances|February 26, 2026
Persistence of PET Scan Positivity After Chemoimmunotherapy For DLBCLJames O Armitage, Matthew A Lunning, Julie M Vose, et al.
Faculty Reviews|September 1, 2023
ALK-positive anaplastic large cell lymphoma in adultsMatthew J Gromowsky, Christopher R D'Angelo, Matthew A Lunning, et al.
Clinical Lymphoma|November 19, 2002
Spontaneous (pathological) splenic rupture in a blastic variant of mantle cell lymphoma: a case report and literature reviewMatthew A Lunning, Maryalice Stetler-Stevenson, Peter T Silberstein, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|October 18, 2019
CAR T-Cell Therapy in Hematologic Malignancies: A Voyage in ProgressSarah A Holstein, Matthew A Lunning
Blood Reviews|October 16, 2012
Management of indolent lymphoma: where are we now and where are we goingMatthew A Lunning, Julie M Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curveMatthew A Lunning, Alison J Moskowitz, Steven Horwitz
Blood|March 12, 2014
How I treat the peripheral T-cell lymphomasAlison J Moskowitz, Matthew A Lunning, Steven M Horwitz
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for longAlison J Moskowitz, Matthew A Lunning, Steven M Horwitz
Journal of Oncology Practice|August 16, 2017
Detection and Treatment of Monoclonal Gammopathy of Renal Significance With Progression to Light Chain Deposition DiseaseGheorghe Ciprian Cazan, Kirk Foster, Matthew A Lunning, et al.
Lancet (London, England)|February 4, 2017
Non-Hodgkin lymphomaJames O Armitage, Randy D Gascoyne, Matthew A Lunning, et al.
Blood Advances|February 26, 2026
Persistence of PET Scan Positivity After Chemoimmunotherapy For DLBCLJames O Armitage, Matthew A Lunning, Julie M Vose, et al.
Faculty Reviews|September 1, 2023
ALK-positive anaplastic large cell lymphoma in adultsMatthew J Gromowsky, Christopher R D'Angelo, Matthew A Lunning, et al.
Clinical Lymphoma|November 19, 2002
Spontaneous (pathological) splenic rupture in a blastic variant of mantle cell lymphoma: a case report and literature reviewMatthew A Lunning, Maryalice Stetler-Stevenson, Peter T Silberstein, et al.
Pageof 7